chr3-70977675-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_001349338.3(FOXP1):c.1396C>A(p.Pro466Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P466L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001349338.3 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability-severe speech delay-mild dysmorphism syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital heart diseaseInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001349338.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FOXP1 | NM_001349338.3 | MANE Select | c.1396C>A | p.Pro466Thr | missense | Exon 16 of 21 | NP_001336267.1 | ||
| FOXP1 | NM_001244810.2 | c.1396C>A | p.Pro466Thr | missense | Exon 16 of 21 | NP_001231739.1 | |||
| FOXP1 | NM_001244814.3 | c.1396C>A | p.Pro466Thr | missense | Exon 12 of 17 | NP_001231743.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FOXP1 | ENST00000649528.3 | MANE Select | c.1396C>A | p.Pro466Thr | missense | Exon 16 of 21 | ENSP00000497369.1 | ||
| FOXP1 | ENST00000318789.11 | TSL:1 | c.1396C>A | p.Pro466Thr | missense | Exon 16 of 21 | ENSP00000318902.5 | ||
| ENSG00000285708 | ENST00000647725.1 | c.1396C>A | p.Pro466Thr | missense | Exon 21 of 26 | ENSP00000497585.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Intellectual disability-severe speech delay-mild dysmorphism syndrome Uncertain:1
The variant is not observed in the gnomAD v4.1.0 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.83 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.99 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported to be associated with FOXP1-related disorder (ClinVar ID: VCV001013484).Different missense changes at the same codon (p.Pro466Ala, p.Pro466Leu) have been reported to be associated with FOXP1-related disorder (ClinVar ID: VCV000374144, VCV003256796). However the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at